Biphenyl amide p38 kinase inhibitors 4: DFG-in and DFG-out binding modes

Bioorg Med Chem Lett. 2008 Aug 1;18(15):4433-7. doi: 10.1016/j.bmcl.2008.06.028. Epub 2008 Jun 12.

Abstract

The biphenyl amides (BPAs) are a series of p38alpha MAP kinase inhibitors. Compounds are able to bind to the kinase in either the DFG-in or DFG-out conformation, depending on substituents. X-ray, binding, kinetic and cellular data are shown, providing the most detailed comparison to date between potent compounds from the same chemical series that bind to different p38alpha conformations. DFG-out-binding compounds could be made more potent than DFG-in-binding compounds by increasing their size. Unexpectedly, compounds that bound to the DGF-out conformation showed diminished selectivity. The kinetics of binding to the isolated enzyme and the effects of compounds on cells were largely unaffected by the kinase conformation bound.

MeSH terms

  • Amides / blood
  • Amides / chemical synthesis*
  • Amides / chemistry
  • Amides / pharmacology*
  • Amino Acids / genetics
  • Amino Acids / metabolism
  • Binding Sites
  • Biphenyl Compounds / blood
  • Biphenyl Compounds / chemical synthesis*
  • Biphenyl Compounds / chemistry
  • Biphenyl Compounds / pharmacology*
  • Combinatorial Chemistry Techniques
  • Crystallography, X-Ray
  • Drug Design
  • Lipopolysaccharides / pharmacology
  • Mitogen-Activated Protein Kinase 14 / antagonists & inhibitors*
  • Molecular Conformation
  • Molecular Structure
  • Naphthalenes / pharmacology
  • Pyrazoles / pharmacology
  • Structure-Activity Relationship

Substances

  • Amides
  • Amino Acids
  • Biphenyl Compounds
  • Lipopolysaccharides
  • Naphthalenes
  • Pyrazoles
  • Mitogen-Activated Protein Kinase 14
  • doramapimod